Wakefield, RI, United States of America

Robert D Torgerson

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: C. R. Bard, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert D Torgerson. Retrieved from https://idiyas.com/inventor/robert-d-torgerson-6orpxyvy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 221(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Robert D. Torgerson

Introduction

Robert D. Torgerson is a notable inventor based in Wakefield, RI (US). He has made significant contributions to the field of medical devices, particularly in hemostatic technologies. With a total of 2 patents, Torgerson's work focuses on innovative solutions for controlling bleeding.

Latest Patents

Torgerson's latest patents include the development of a collagen hemostatic foam and collagen hemostatic fibers. The collagen hemostatic foam is a device formed of collagen particles designed to control bleeding effectively. This device utilizes collagen particles that exhibit hemostatic activity equivalent to that of the original collagen. The foam can also incorporate additional hemostatic and therapeutic agents to enhance wound healing. Additionally, the collagen hemostatic fibers are designed to prepare hemostatic fabrics, which also aim to control bleeding. These fibers are made from collagen particles that maintain their hemostatic properties, and they can include various agents to further promote healing.

Career Highlights

Torgerson is associated with C. R. Bard, Inc., a company known for its innovative medical technologies. His work at this organization has allowed him to contribute to advancements in medical devices that address critical health challenges.

Collaborations

Throughout his career, Torgerson has collaborated with notable colleagues, including Francis B. Maddalo and Stephen N. Eldridge. These collaborations have likely enriched his research and development efforts in the medical field.

Conclusion

Robert D. Torgerson's contributions to hemostatic technologies demonstrate his commitment to improving medical devices for better patient outcomes. His innovative patents reflect a deep understanding of the needs in medical care and the potential for advancements in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…